MDT

$99.312.87%2.77

Dopo l'orario di chiusura: 98.88-0.43 -0.43%

Medtronic Plc (MDT)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$96.54

Aprire:

$96.94

Volume 24 ore:

6,980,851

Volume relativo:

0.77

Capitalizzazione di mercato:

$127.03B

Reddito:

$36.36B

Utile/perdita netta:

$4.84B

Rapporto P/E:

26.65

EPS:

$3.73

Flusso di cassa netto:

$5.43B

1W Prestazione:

+4.77%

1M Prestazione:

+14.97%

6M Prestazione:

+24.14%

1Y Prestazione:

+9.49%

Intervallo 1D:

$96.75$99.48

Intervallo di 1 settimana:

$93.04$99.48

Portata 52W:

$73.31$106.33

Profilo aziendale di Medtronic Plc (MDT)

Nome

Medtronic Plc

Settore

Healthcare

Industria

Medical Devices

Telefono

01135314381700

Indirizzo

BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY, Ireland

Dipendente

95,000

@Medtronic

Prossima data di guadagno

2026-11-17

Ultimi documenti SEC

SEC

Discussioni di MDT su X

Confronta MDT con ABT, SYK, BSX, EW

Azioni	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MDT Medtronic Plc	$127.03B	$37.54B	$5.23B	$6.13B	$3.73
ABT Abbott Laboratories	$190.83B	$45.13B	$6.28B	$7.38B	$3.09
SYK Stryker Corp	$117.68B	$26.30B	$3.62B	$4.57B	$8.63
BSX Boston Scientific Corp	$64.24B	$21.07B	$3.50B	$3.33B	$2.38
EW Edwards Lifesciences Corp	$53.76B	$6.51B	$1.00B	$1.43B	$1.84

Medtronic Plc Azioni (MDT) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-10-07	Iniziato	Barclays	Equal Weight
2026-08-27	Reiterato	Needham	Buy
2026-07-28	Aggiornamento	UBS	Neutral → Buy
2026-06-04	Aggiornamento	BTIG Research	Neutral → Buy
2026-05-21	Resumed	Goldman	Neutral
2026-02-13	Resumed	Barclays	Overweight
2026-02-09	Aggiornamento	Needham	Hold → Buy
2026-02-03	Resumed	Citigroup	Buy
2026-01-30	Resumed	Wells Fargo	Overweight
2026-01-06	Aggiornamento	William Blair	Mkt Perform → Outperform
2025-11-19	Aggiornamento	Goldman	Sell → Neutral
2025-06-30	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2025-06-16	Iniziato	Leerink Partners	Outperform
2025-03-04	Aggiornamento	Citigroup	Neutral → Buy
2024-10-10	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2024-08-21	Reiterato	Oppenheimer	Perform
2024-08-15	Aggiornamento	UBS	Sell → Neutral
2024-08-14	Downgrade	Stifel	Buy → Hold
2024-05-30	Iniziato	Goldman	Sell
2023-07-19	Iniziato	Robert W. Baird	Neutral
2023-06-30	Iniziato	CL King	Buy
2023-05-30	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-04-24	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-03-29	Downgrade	UBS	Buy → Sell
2023-01-09	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-11-23	Downgrade	Citigroup	Buy → Neutral
2022-11-23	Downgrade	Oppenheimer	Outperform → Perform
2022-11-16	Downgrade	Deutsche Bank	Buy → Hold
2022-10-18	Iniziato	Barclays	Equal Weight
2022-10-13	Iniziato	Mizuho	Buy
2022-10-12	Iniziato	Jefferies	Hold
2022-08-24	Downgrade	Raymond James	Outperform → Mkt Perform
2022-07-06	Iniziato	Wolfe Research	Underperform
2022-06-01	Downgrade	Atlantic Equities	Overweight → Neutral
2022-05-27	Downgrade	Needham	Buy → Hold
2022-04-13	Downgrade	Truist	Buy → Hold
2022-03-02	Resumed	BofA Securities	Buy
2022-01-10	Downgrade	BTIG Research	Buy → Neutral
2022-01-07	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-01-04	Downgrade	Piper Sandler	Overweight → Neutral
2021-12-17	Downgrade	JP Morgan	Overweight → Neutral
2021-12-16	Downgrade	Wells Fargo	Overweight → Equal Weight
2021-12-10	Iniziato	RBC Capital Mkts	Outperform
2021-06-10	Resumed	Cowen	Outperform
2021-05-25	Iniziato	Barclays	Equal Weight
2021-04-15	Iniziato	Atlantic Equities	Overweight
2020-12-15	Aggiornamento	Goldman	Sell → Neutral
2020-12-15	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-10-08	Aggiornamento	Bernstein	Mkt Perform → Outperform
2020-10-08	Aggiornamento	Stifel	Hold → Buy
2020-09-11	Iniziato	Wolfe Research	Peer Perform
2020-05-14	Downgrade	DZ Bank	Buy → Hold
2020-03-30	Downgrade	Needham	Strong Buy → Buy
2020-03-25	Aggiornamento	DZ Bank	Hold → Buy
2020-03-05	Iniziato	Citigroup	Buy
2020-02-13	Iniziato	Goldman	Sell
2020-01-08	Iniziato	SunTrust	Buy
2020-01-02	Aggiornamento	Guggenheim	Neutral → Buy
2019-06-05	Aggiornamento	Wells Fargo	Market Perform → Outperform
2019-02-04	Reiterato	Needham	Strong Buy
2019-01-03	Iniziato	Deutsche Bank	Buy
2019-01-02	Downgrade	Citigroup	Buy → Neutral
2018-12-19	Aggiornamento	JP Morgan	Neutral → Overweight
2018-11-28	Iniziato	UBS	Buy
2018-10-16	Iniziato	Barclays	Overweight
2018-08-27	Reiterato	Argus	Buy

Medtronic Plc Azioni (MDT) Dati Finanziari

Periodo	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Data di fine periodo	2026-04-24	2025-04-25	2024-04-26	2023-04-28	2022-04-29
Revenue USD (M)	36,364.00	33,537.00	32,364.00	31,227.00	31,686.00
Cost of revenue USD (M)	12,721.00	11,632.00	11,216.00	10,719.00	10,145.00
Gross profit USD (M)	-	-	-	20,508.00	21,541.00
Operating expenses USD (M)	-	-	-	15,023.00	15,789.00
Operating income USD (M)	6,467.00	5,955.00	5,144.00	5,485.00	5,752.00
Income before tax USD (M)	6,136.00	5,628.00	4,837.00	5,364.00	5,517.00
Income tax expense USD (M)	1,299.00	936.00	1,133.00	1,580.00	456.00
Net income USD (M)	4,837.00	4,691.00	3,705.00	3,784.00	5,062.00
Basic EPS USD/shares	3.75	3.63	2.77	2.83	3.75
Diluted EPS USD/shares	3.73	3.61	2.76	2.82	3.73
Basic weighted shares shares (M)	1,281.80	1,285.60	1,327.70	1,329.80	1,342.40
Diluted weighted shares shares (M)	1,288.10	1,289.90	1,330.20	1,332.80	1,351.40
Selling, general and administrative USD (M)	11,784.00	10,849.00	10,736.00	10,415.00	10,292.00

Medtronic Plc Azioni (MDT) insider trading

Marinaro MichaelOct 15 '26
Officer
Transazione
Proposed Sale
Costo
$96.00
#Azioni
10,420
Valore ($)
1,000,320
#Azioni Totale
0
Martha GeoffreyOct 15 '26
Chairman and CEO
Transazione
Sale
Costo
$95.00
#Azioni
50,000
Valore ($)
4,750,000
#Azioni Totale
277,866
Marinaro MichaelOct 15 '26
EVP, Pres MedSurg and Americas
Transazione
Sale
Costo
$96.00
#Azioni
10,420
Valore ($)
1,000,320
#Azioni Totale
105,916
Martha GeoffreyOct 15 '26
Officer
Transazione
Proposed Sale
Costo
$95.00
#Azioni
50,000
Valore ($)
4,750,000
#Azioni Totale
0
KIIL HARRY SKIPSep 16 '26
EVP & President Cardiovascular
Transazione
Sale
Costo
$93.65
#Azioni
1,483
Valore ($)
138,883
#Azioni Totale
42,186
KIIL HARRY SKIPSep 16 '26
Officer
Transazione
Proposed Sale
Costo
$93.65
#Azioni
1,483
Valore ($)
138,889
#Azioni Totale
0
Walter Matthew R.Jul 08 '26
SVP, Chief HR Officer
Transazione
Sale
Costo
$83.15
#Azioni
3,102
Valore ($)
257,931
#Azioni Totale
35,694
Walter Matthew R.Jul 08 '26
Officer
Transazione
Proposed Sale
Costo
$83.15
#Azioni
3,102
Valore ($)
257,931
#Azioni Totale
0
KIIL HARRY SKIPJun 08 '26
EVP & President Cardiovascular
Transazione
Sale
Costo
$80.44
#Azioni
4,189
Valore ($)
336,965
#Azioni Totale
37,227
KIIL HARRY SKIPJun 08 '26
Officer
Transazione
Proposed Sale
Costo
$80.44
#Azioni
4,189
Valore ($)
336,965
#Azioni Totale
0

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Marinaro Michael	Officer	Oct 15 '26	Proposed Sale	$96.00	10,420	1,000,320	0
Martha Geoffrey	Chairman and CEO	Oct 15 '26	Sale	$95.00	50,000	4,750,000	277,866
Marinaro Michael	EVP, Pres MedSurg and Americas	Oct 15 '26	Sale	$96.00	10,420	1,000,320	105,916
Martha Geoffrey	Officer	Oct 15 '26	Proposed Sale	$95.00	50,000	4,750,000	0
KIIL HARRY SKIP	EVP & President Cardiovascular	Sep 16 '26	Sale	$93.65	1,483	138,883	42,186
KIIL HARRY SKIP	Officer	Sep 16 '26	Proposed Sale	$93.65	1,483	138,889	0
Walter Matthew R.	SVP, Chief HR Officer	Jul 08 '26	Sale	$83.15	3,102	257,931	35,694
Walter Matthew R.	Officer	Jul 08 '26	Proposed Sale	$83.15	3,102	257,931	0
KIIL HARRY SKIP	EVP & President Cardiovascular	Jun 08 '26	Sale	$80.44	4,189	336,965	37,227
KIIL HARRY SKIP	Officer	Jun 08 '26	Proposed Sale	$80.44	4,189	336,965	0

Medtronic Plc Borsa (MDT) Ultime notizie

Nov 02, 2026

The Best Dividend Stocks to Buy With $5,000 in November - The Motley Fool

Nov 02, 2026

Nov 01, 2026

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy? - The Motley Fool

Nov 01, 2026

Oct 30, 2026

JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4? - Zacks Investment Research

Oct 30, 2026

Oct 29, 2026

Why the Market Dipped But Medtronic (MDT) Gained Today - Zacks Investment Research

Oct 29, 2026